Literature DB >> 11012881

Nephrin in experimental glomerular disease.

P Luimula1, H Ahola, S X Wang, M L Solin, P Aaltonen, I Tikkanen, D Kerjaschki, H Holthöfer.   

Abstract

BACKGROUND: The recently identified gene NPHS1 with its mutations causing congenital nephrotic syndrome of the Finnish type (CNF) is highly promising in providing new understanding of pathophysiology of proteinuria. Earlier we cloned a rat NPHS1 homologue, as well as characterized and raised antibodies to the respective protein product nephrin.
METHODS: Changes in the expression levels of nephrin-specific mRNA in commonly used experimental models of proteinuria were examined using semiquantitative reverse transcription-polymerase chain reaction, immunofluorescence, and immunoelectron microscopy (IEM) of nephrin.
RESULTS: Notably, a 40% down-regulation of the nephrin-specific mRNA of cortical kidney was seen already at day 3 after induction of the puromycin aminonucleoside nephrosis (PAN), while no major elevation of urinary protein secretion was seen at this stage. A further decrease of 80% of nephrin message was seen at the peak of proteinuria at day 10. A similar decrease of up to 70% from the basal levels was seen in mercuric chloride-treated rats. Changes in the protein expression paralleled those of the mRNA in indirect immunofluorescence. Interestingly, a remarkable plasmalemmal dislocation from the normal expression site at the interpodocyte filtration slits could be observed in IEM.
CONCLUSIONS: Nephrin appears to be an important causative molecule of proteinuria and shows a remarkable redistribution from the filtration slits to the podocyte plasma membrane, especially in PAN.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11012881     DOI: 10.1046/j.1523-1755.2000.00308.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  29 in total

Review 1.  Pathogenesis of proteinuria: lessons learned from nephrin and podocin.

Authors:  Hannu Jalanko
Journal:  Pediatr Nephrol       Date:  2003-06       Impact factor: 3.714

2.  Inducible nephrin transgene expression in podocytes rescues nephrin-deficient mice from perinatal death.

Authors:  Juuso Juhila; Markus Lassila; Ramon Roozendaal; Eero Lehtonen; Marcel Messing; Brigitte Langer; Dontscho Kerjaschki; J Sjef Verbeek; Harry Holthofer
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

3.  Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.

Authors:  Maho Yamashita; Tadashi Yoshida; Sayuri Suzuki; Koichiro Homma; Matsuhiko Hayashi
Journal:  Clin Exp Nephrol       Date:  2016-04-18       Impact factor: 2.801

4.  Podocyte-Specific Sialylation-Deficient Mice Serve as a Model for Human FSGS.

Authors:  Kristina M Niculovic; Linda Blume; Henri Wedekind; Elina Kats; Iris Albers; Stephanie Groos; Markus Abeln; Jessica Schmitz; Esther Beuke; Jan H Bräsen; Anette Melk; Mario Schiffer; Birgit Weinhold; Anja K Münster-Kühnel
Journal:  J Am Soc Nephrol       Date:  2019-04-30       Impact factor: 10.121

5.  Inducible Expression of Claudin-1 in Glomerular Podocytes Generates Aberrant Tight Junctions and Proteinuria through Slit Diaphragm Destabilization.

Authors:  Yongfeng Gong; Abby Sunq; Robyn A Roth; Jianghui Hou
Journal:  J Am Soc Nephrol       Date:  2016-05-05       Impact factor: 10.121

6.  Plasma concentration of urokinase plasminogen activator receptor is a marker of kidney allograft function.

Authors:  Marzena Staniszewska; Violetta Dziedziejko; Ewa Kwiatkowska; Marta Tkacz; Kamila Puchałowicz; Krzysztof Safranow; Leszek Domanski; Andrzej Pawlik
Journal:  Ir J Med Sci       Date:  2018-03-01       Impact factor: 1.568

7.  Glomerular structural factors in progression of congenital nephrotic syndrome.

Authors:  Abhay N Vats; Brian Costello; Michael Mauer
Journal:  Pediatr Nephrol       Date:  2003-02-26       Impact factor: 3.714

8.  De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.

Authors:  Takamoto Ohse; Michael R Vaughan; Jeffrey B Kopp; Ronald D Krofft; Caroline B Marshall; Alice M Chang; Kelly L Hudkins; Charles E Alpers; Jeffrey W Pippin; Stuart J Shankland
Journal:  Am J Physiol Renal Physiol       Date:  2009-12-09

9.  Beneficial effects of the Rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis.

Authors:  Liming Wang; Mathew J Ellis; Timothy A Fields; David N Howell; Robert F Spurney
Journal:  Kidney Blood Press Res       Date:  2008-03-27       Impact factor: 2.687

10.  Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.

Authors:  Beom Seok Kim; Hyeong Cheon Park; Shin Wook Kang; Kyu Hun Choi; Sung Kyu Ha; Dae Suk Han; Ho Yung Lee
Journal:  Yonsei Med J       Date:  2005-02-28       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.